Concepts (95)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Veins | 5 | 2015 | 709 | 0.420 |
Why?
|
| Atrial Fibrillation | 10 | 2015 | 4454 | 0.320 |
Why?
|
| Catheter Ablation | 7 | 2015 | 2506 | 0.300 |
Why?
|
| Anti-Arrhythmia Agents | 3 | 2007 | 756 | 0.240 |
Why?
|
| Tachycardia, Atrioventricular Nodal Reentry | 1 | 2003 | 130 | 0.230 |
Why?
|
| Heart Block | 2 | 2005 | 410 | 0.230 |
Why?
|
| Blood Chemical Analysis | 1 | 2003 | 460 | 0.210 |
Why?
|
| Troponin I | 1 | 2003 | 632 | 0.180 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2000 | 593 | 0.160 |
Why?
|
| Magnetic Resonance Angiography | 3 | 2015 | 1481 | 0.160 |
Why?
|
| Electrocardiography | 4 | 2003 | 6386 | 0.150 |
Why?
|
| Phlebography | 1 | 2015 | 328 | 0.130 |
Why?
|
| Blood Coagulation | 2 | 2010 | 1114 | 0.100 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2000 | 2144 | 0.100 |
Why?
|
| International Normalized Ratio | 1 | 2010 | 364 | 0.090 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 2 | 2007 | 465 | 0.080 |
Why?
|
| Pulmonary Veno-Occlusive Disease | 1 | 2005 | 64 | 0.070 |
Why?
|
| Myocardial Infarction | 2 | 2003 | 11323 | 0.070 |
Why?
|
| Drug Monitoring | 1 | 2010 | 936 | 0.060 |
Why?
|
| Autoanalysis | 1 | 2003 | 77 | 0.060 |
Why?
|
| Cardiac Volume | 1 | 2004 | 214 | 0.060 |
Why?
|
| Heparin | 1 | 2010 | 1625 | 0.060 |
Why?
|
| Tachycardia | 1 | 2004 | 608 | 0.050 |
Why?
|
| False Positive Reactions | 1 | 2003 | 1004 | 0.050 |
Why?
|
| Contrast Media | 2 | 2004 | 5267 | 0.050 |
Why?
|
| Gadolinium DTPA | 1 | 2004 | 827 | 0.050 |
Why?
|
| Radiographic Image Enhancement | 1 | 2004 | 924 | 0.040 |
Why?
|
| Heart Conduction System | 1 | 2004 | 1030 | 0.040 |
Why?
|
| Hemorrhage | 1 | 2010 | 3235 | 0.040 |
Why?
|
| Heart Atria | 1 | 2004 | 1286 | 0.040 |
Why?
|
| Computer-Assisted Instruction | 1 | 2001 | 379 | 0.040 |
Why?
|
| Thromboembolism | 1 | 2003 | 985 | 0.040 |
Why?
|
| Health Resources | 1 | 2003 | 922 | 0.040 |
Why?
|
| RNA, Fungal | 1 | 1997 | 166 | 0.040 |
Why?
|
| RNA, Catalytic | 1 | 1997 | 110 | 0.040 |
Why?
|
| RNA Precursors | 1 | 1997 | 216 | 0.040 |
Why?
|
| Ventricular Remodeling | 1 | 2003 | 1280 | 0.030 |
Why?
|
| Endoribonucleases | 1 | 1997 | 219 | 0.030 |
Why?
|
| Anticoagulants | 1 | 2010 | 4293 | 0.030 |
Why?
|
| Costs and Cost Analysis | 1 | 2000 | 1652 | 0.030 |
Why?
|
| RNA, Transfer | 1 | 1997 | 309 | 0.030 |
Why?
|
| Nucleic Acid Conformation | 1 | 1997 | 961 | 0.030 |
Why?
|
| Educational Measurement | 1 | 2001 | 1271 | 0.030 |
Why?
|
| Emergency Medical Services | 1 | 2003 | 1746 | 0.030 |
Why?
|
| Disease Management | 1 | 2003 | 2536 | 0.030 |
Why?
|
| Heart Rate | 1 | 2003 | 4094 | 0.030 |
Why?
|
| Time Factors | 4 | 2015 | 41038 | 0.030 |
Why?
|
| Treatment Outcome | 5 | 2015 | 61932 | 0.030 |
Why?
|
| Middle Aged | 10 | 2015 | 213752 | 0.020 |
Why?
|
| Predictive Value of Tests | 3 | 2015 | 15252 | 0.020 |
Why?
|
| Humans | 15 | 2015 | 708843 | 0.020 |
Why?
|
| Incidence | 2 | 2003 | 20320 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2000 | 5235 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2010 | 23284 | 0.020 |
Why?
|
| Multivariate Analysis | 2 | 2015 | 12447 | 0.020 |
Why?
|
| Female | 11 | 2015 | 375205 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2010 | 71483 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2004 | 16008 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2003 | 7487 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2004 | 39038 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 6765 | 0.020 |
Why?
|
| Male | 10 | 2015 | 349524 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 3562 | 0.020 |
Why?
|
| Recurrence | 1 | 2015 | 8255 | 0.020 |
Why?
|
| Boston | 2 | 2010 | 9402 | 0.010 |
Why?
|
| Adult | 5 | 2015 | 211041 | 0.010 |
Why?
|
| Prospective Studies | 4 | 2015 | 50597 | 0.010 |
Why?
|
| Risk Factors | 4 | 2015 | 69553 | 0.010 |
Why?
|
| Warfarin | 1 | 2010 | 1440 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2010 | 5045 | 0.010 |
Why?
|
| Aged | 5 | 2010 | 161488 | 0.010 |
Why?
|
| Diastole | 1 | 2004 | 836 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2003 | 58184 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2010 | 6451 | 0.010 |
Why?
|
| Hospital Information Systems | 1 | 2001 | 362 | 0.010 |
Why?
|
| Ribonuclease P | 1 | 1997 | 15 | 0.010 |
Why?
|
| Observer Variation | 1 | 2004 | 2687 | 0.010 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2004 | 935 | 0.010 |
Why?
|
| Hydrolysis | 1 | 1997 | 728 | 0.010 |
Why?
|
| United States | 1 | 2003 | 67165 | 0.010 |
Why?
|
| Linear Models | 1 | 2004 | 5986 | 0.010 |
Why?
|
| Chest Pain | 1 | 2000 | 1100 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 1997 | 1897 | 0.010 |
Why?
|
| Ventricular Function, Left | 1 | 2004 | 3411 | 0.010 |
Why?
|
| Health Care Costs | 1 | 2003 | 3152 | 0.010 |
Why?
|
| Education, Medical | 1 | 2001 | 1683 | 0.010 |
Why?
|
| Internet | 1 | 2001 | 3074 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2004 | 19423 | 0.000 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1997 | 2930 | 0.000 |
Why?
|
| Sensitivity and Specificity | 1 | 2000 | 14836 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 2000 | 13274 | 0.000 |
Why?
|
| Hospitalization | 1 | 2003 | 9644 | 0.000 |
Why?
|
| Algorithms | 1 | 2003 | 13647 | 0.000 |
Why?
|
| Cohort Studies | 1 | 2005 | 39292 | 0.000 |
Why?
|
| Prognosis | 1 | 2000 | 28919 | 0.000 |
Why?
|
Concepts
(95)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(15)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_